ACTRIMS 2022 | The central vein sign in multiple sclerosis

Pascal Sati, PhD, Cedars-Sinai Medical Center, Los Angeles, CA, discusses a study exploring the central vein sign (CVS) as an imaging biomarker of multiple sclerosis (MS) pathophysiology. After following patients over three years, it was observed that patients who formed a greater number of new CVS-positive lesions tended to be younger and have a higher rate of CVS-positive lesions at baseline. Dr Sati emphasizes CVS as a valuable tool for capturing MS disease activity and to differentiate MS activity from other comorbidities. This interview took place at the ACTRIMS Forum 2022 in West Palm Beach, Florida.